CHICAGO, Aug. 12, 2013 /PRNewswire/ -- Allscripts today announced that its Enterprise 11.4.1 and Professional 13.0 Electronic Health Records (EHRs) have been tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program. This EHR software is compliant in accordance with the criteria adopted by the Secretary of the U.S. Department of Health and Human Services. 

"The Meaningful Use 2014 certification of our Enterprise and Professional EHRs is a critical deliverable we committed to our clients," said Paul M Black, President and Chief Executive Officer of Allscripts. "By having all of our core clinical solutions Meaningful Use 2014 certified, we will drive further operational excellence."

Drummond Group's ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology – a key component of the federal government's push to improve clinical care delivery through the adoption and effective use of EHRs by U.S. healthcare providers.

The following Allscripts products are 2014 Edition compliant and have been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments."

Allscripts Enterprise EHR 11.4.1 (Two complete Ambulatory certifications, one with Allscripts FollowMyHealth™ and one with Allscripts Patient Portal powered by Intuit.)

Allscripts Enterprise EHR (Certified with Allscripts FollowMyHealth™)

Certified 8/2/13, Version 11.4.1, Criteria Certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7) 170.314(c)(1‐3); 170.314(d)(1‐9); 170.314(e)(1‐3); 170.314(f)(1‐3); 170.314(g)(2‐4), Certification ID Number: 08022013‐1888‐1, Clinical Quality Measures tested: CMS050v1; CMS075v1; CMS122v1; CMS126v1; CMS127v1; CMS130v1; CMS146v1; CMS153v1; CMS154v1; CMS155v1; CMS156v1; CMS165v1. Additional software used: Allscripts Meaningful Use Package – 2014 Edition, MedAllies Direct Solutions v1.0, Allscripts FollowMyHealth™ v2.0.

Allscripts Enterprise EHR (Certified with Allscripts Patient Portal Powered by Intuit)

Certified 8/2/13, Version 11.4.1, Criteria Certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7); 170.314(c)(1‐3); 170.314(d)(1‐9); 170.314(e)(1‐3); 170.314(f)(1‐3); 170.314(g)(2‐4), Certification ID Number: 08022013‐1889‐1, Clinical Quality Measures tested: CMS050v1; CMS075v1; CMS122v1; CMS126v1; CMS127v1; CMS130v1; CMS146v1; CMS153v1; CMS154v1; CMS155v1; CMS156v1; CMS165v1. Additional software used: Allscripts Meaningful Use Package – 2014 Edition, MedAllies Direct Solutions v1.0, Allscripts Patient Portal Powered by Intuit v13.3

Allscripts Enterprise EHR 11.4.1 (Modular, Ambulatory certification.)

Allscripts Enterprise EHR (Modular)

Certified 8/2/13, Version 11.4.1, Criteria Certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7); 170.314(c)(1‐3); 170.314(d)(1‐9); 170.314(e)(2); 170.314(f)(1-3); 170.314(g)(2-4), Certification ID Number: 08022013‐1890‐1, Clinical Quality Measures tested: CMS050v1; CMS075v1; CMS122v1; CMS126v1; CMS127v1; CMS153v1; CMS154v1; CMS130v1; CMS146v1; CMS155v1; CMS156v1; CMS165v1. Additional software used: Allscripts Meaningful Use Package – 2014 Edition, MedAllies Direct Solutions v1.0.

Allscripts Professional EHR 13.0 (Two complete Ambulatory certifications, one with Allscripts FollowMyHealth™ and one with Allscripts Patient Portal powered by Intuit portals.)

Allscripts Professional EHR Certified with Allscripts FollowMyHealth™

Certified 8/2/13, Version 13.0, Criteria Certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7); 170.314(c)(1‐3); 170.314(d)(1‐9); 170.314(e)(1‐3); 170.314(f)(1‐3); 170.314(g)(2‐4), Certification ID Number: 08022013‐2047‐6, Clinical Quality Measures tested: CMS146v1; CMS165v1; CMS156v1; CMS155v1; CMS138v1; CMS153v1; CMS126v1; CMS166v1; CMS122v1; CMS163v1; CMS154v1; CMS069v1; CMS075v1. Additional software used: Allscripts Meaningful Use Package – 2014 Edition, MedAllies Direct Solutions V1.0, Allscripts FollowMyHealth™ v2.0.

Allscripts Professional EHR (Certified with Allscripts Patient Portal Powered by Intuit)

Certified 8/2/13, Version 13.0, Criteria Certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7); 170.314(c)(1‐3); 170.314(d)(1‐9); 170.314(e)(1‐3); 170.314(f)(1‐3); 170.314(g)(2‐4), Certification ID Number: 08022013‐2048‐6, Clinical Quality Measures tested: CMS146v1; CMS165v1; CMS156v1; CMS155v1; CMS138v1; CMS153v1; CMS126v1; CMS166v1; CMS122v1; CMS163v1; CMS154v1; CMS069v1; CMS075v1. Additional software used: Allscripts Meaningful Use Package – 2014 Edition, MedAllies Direct Solutions, Allscripts Patient Portal Powered by Intuit.

Price Transparency

Licensing and implementation of the functionality and content covered by this certification will require ongoing and/or one-time license and/or service fees covering the right to use the in-scope solutions, support, and requested standard implementation, integration, and consulting services.  Required connectivity for transmitting patient data will require one-time costs, ongoing service fees, and/or transaction-based fees. 

*A certification that is issued to an integrated bundle of EHR Modules shall be treated the same as a certification issued to a Complete EHR except that it must also indicate each EHR Module that comprises the bundle;

*A certification issued to a Complete EHR or EHR Module based on applicable certification criteria adopted by the ONC at subpart C of this part must be separate and distinct from any other certification(s) based on other criteria or requirements.

About Allscripts

Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About Drummond Group Inc.

Drummond Group Inc. is a global software test and certification lab that serves a wide range of vertical industries.  In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Authorized Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit http://www.drummondgroup.com or email DGI@drummondgroup.com.

© 2013 Allscripts Healthcare, LLC. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are either registered trademarks or trademarks of Allscripts Healthcare, LLC in the United States and/or other countries.  All other trademarks are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that our current initiatives focused on product delivery, client experience, streamlining our cost structure, and financial performance may not be successful, which could result in declining demand for our products and services, including attrition among our existing customer base; the impact of the realignment of our sales and services organization; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risks that we will not achieve the strategic benefits of the merger with Eclipsys Corporation (Eclipsys) or our acquisition of dbMotion, Ltd. (dbMotion), or that the Allscripts products will not be integrated successfully with the Eclipsys and dbMotion products; competition within the industries in which we operate, including the risk that existing clients will switch to products of competitors; failure to maintain interoperability certification pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH), with resulting increases in development and other costs for us and possibly putting us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; any costs or customer losses we may incur relating to the standardization of our small office electronic health record and practice management systems that could adversely affect our results of operations; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; errors or similar problems in our software products or other product quality issues; the outcome of any legal proceeding that has been or may be instituted against us and others; compliance obligations under new and existing laws, regulations and industry initiatives, including new regulations relating to HIPAA/HITECH, increasing enforcement activity in respect of anti-bribery, fraud and abuse, privacy, and similar laws, and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the continued implementation and ongoing acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009, as well as elements of the Patient Protection and Affordable Care Act (aka health reform) which pertain to healthcare IT adoption, including uncertainty related to changes in reimbursement methodology and the shift to pay-for-outcomes; maintaining our intellectual property rights and litigation involving intellectual property rights; legislative, regulatory and economic developments; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; breach of data security by third parties and unauthorized access to patient health information by third parties resulting in enforcement actions, fines and other litigation. See our Annual Report on Form 10-K/10K-A for 2012 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.

(Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO )

SOURCE Allscripts Healthcare Solutions, Inc.

Investors: Seth Frank, 312-506-1213, seth.frank@allscripts.com; Media: Claire Weingarden, 312-447-2442, claire.weingarden@allscripts.com